SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?


To: Wildbiftek who wrote (5630)12/17/2019 11:16:08 PM
From: Gary Mohilner  Respond to of 5665
 
I'll agree with what you're saying, but I believe the company still believes that other cancers where patients have high platinum resistance may also benefit from the drug as well. I think there has been some anecdotal applications, but additional trials will be required to prove it. If proven, the potential of the drug could grow dramatically.

Gary